Arcus Biosciences (RCUS) Current Taxes (2021 - 2022)
Arcus Biosciences (RCUS) posted quarterly Current Taxes of $18000.0 for Q3 2022, little changed quarter-over-quarter from $18000.0 in Q2 2022.
Analysis
Arcus Biosciences (RCUS) Current Taxes (2021 - 2022) Analysis & Trends
Arcus Biosciences' Current Taxes history runs 2 years deep, the most recent figure standing at $18000.0 for Q3 2022.
- In Q3 2022, Current Taxes changed N/A year-over-year to $18000.0; the TTM figure through Sep 2022 stood at $18000.0 (changed N/A YoY), while the FY2021 annual figure was $2.0 million, changed N/A from the prior year.
- Current Taxes for Q3 2022 stood at $18000.0, roughly flat from $18000.0 in the prior quarter.
- The five-year high for Current Taxes was $2.8 million in Q1 2022, with the low at $18000.0 in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Arcus Biosciences | 3.74 Bn | 3.04 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 18,000.00 |
| Jun 30, 2022 | 18,000.00 |
| Mar 31, 2022 | 2.82 Mn |
| Dec 31, 2021 | 2.00 Mn |